Nardostachys jatamansi improves learning and memory in mice

Journal of Medicinal Food

Volumn 9, Issue 1, 2006, Pages 113-118

  Joshi, Hanumanthachar ^a   Parle, Milind ^b  

^a S E T S COLLEGE OF PHARMACY   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Amnesia; Learning; Memory; Nardostachys jatamansi

Indexed keywords

ALCOHOL; ANIRACETAM; CHOLINESTERASE INHIBITOR; DIAZEPAM; DONEPEZIL; NARDOSTACHYS JATAMANSI EXTRACT; NOOTROPIC AGENT; PIRACETAM; PLANT EXTRACT; SCOPOLAMINE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENTION DEFICIT DISORDER; AYURVEDA; BEHAVIOR DISORDER; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DEMENTIA; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ELEVATED PLUS MAZE TEST; EVALUATION; FEMALE; LEARNING; MALE; MAZE TEST; MEMORY; MOOD DISORDER; MOUSE; NARDOSTACHYS; NARDOSTACHYS JATAMANSII; NONHUMAN; PASSIVE AVOIDANCE; PLANT ROOT; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; CHEMISTRY; MOTOR ACTIVITY;

NARDOSTACHYS JATAMANSI;

AGING; AMNESIA; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DIAZEPAM; FEMALE; LEARNING; MALE; MAZE LEARNING; MEDICINE, AYURVEDIC; MEMORY; MICE; MOTOR ACTIVITY; NARDOSTACHYS; PLANT EXTRACTS; PLANT ROOTS; SCOPOLAMINE;

EID: 33745491889     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.113     Document Type: Article

References (25)

1. Cummings JL, Cole G: Alzheimer's disease. JAMA 2002;287: 2335-2348.
2. Katzman R, Kawas C: Risk factors for Alzheimer's disease. Neuro Sci News 1998;1(4):27-44.
3. Erickson KR: Amnestic disorders. Pathophysiology and patterns of memory dysfunction. West J Med 1990;152:159-166.
4. Higashida A, Ogawa N: Differences in the acquisition process and the effect of scopolamine on radial maze performance in the strains of rats. Pharmacol Biochem Behav 1987;27:483-489.
5. Sitaram N, Weingartner H, Gillin JC: Human serial learning. Enhancement with arecholine and choline and impairment with scopolamine. Science 1978;201:247-276.
6. Preston C, Ward C, Lines CR, Poppleton P, Haigh JRM, Traud M: Scopolamine and benzodiazepine models of dementia-reversal by Ro-15-1788 and physostigmine. Psychopharmacology (Berl) 1989;98:487-494.
7. Singh N, Sharma A, Singh M: Possible mechanism of alprazolam induced amnesia in mice. Pharmacology 1998;56:46-50.
8. Lister RG: The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 1985;9:87-94.
9. Schever K, Rostock A, Bartsch P, Muller WK: Piracetam improved cognitive performance by restoring neurochemical deficits of the aged rat brain. Pharmacopsychiatry 1999;32:10-16.
10. Cumin R, Bandle EF, Gamzu E, Haefely EW: Effects of the novel compound aniracetam (Ro-13-5057) upon impaired learning and memory in rodents. Psychopharmacology (Berl) 1982;78: 104-111.
11. Blazer DG, Federspiel CF, Ray WA, Schaffner W: The risk of anti cholinergic toxicity in the elderly-a study of prescribing practices in two populations. J Gerontol 1983;38:31-35.
12. Rogers SH, Farlow MR, Doody RS, Mohs R, Friedhoff LI; Donepezil Study Group: A 24 week, double blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998;50:136-145.
13. th ed., Chaukambha Bharati Academy, Varanasi, India, 1987, pp. 31-34.
14. The Ayurvedic Formulary of India, Part 1, Government of India, Ministry of Health and Family Planning, Controller of Publications, New Delhi, 1978, pp. 21-22.
15. th ed., Public Information Directorate, CSIR, New Delhi, 1990, pp. 286-287.
16. th ed., Public Information Directorate, CSIR, New Delhi, 1999, pp. 3-4.
17. Tripathi YB, Tripathi E, Upadhyaya A: Antilipid peroxidative property of Nardostachys jatamansi. Indian J Exp Biol 1996;34: 1150-1161.
18. Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F: Protective effect of Nardostachys jatamansi in rat cerebral ischemia. Pharmacol Biochem Behav 2003;74:481-486.
19. Itoh J, Nabeshima T, Kameyama T: Utility of an elevated plus maze for the evaluation of nootropics, scopolamine and electro convulsive shock. Psychopharmacology (Berl) 1990;101: 27-33.
20. Joshi H, Parle M: Effects of pipeline on memory and behavior mediated via monoamine neurotransmitters. J Tradit Med 2005;2:39-43.
21. Nagy IZ: On the true role of oxygen free radicals in the living state, ageing and degenerative disorders. Ann N Y Acad Sci 2001;928:187-199.
22. Plan JC, Zhang SS: Antagonism of piracetam on the amnesic effect of diazepam in mice. Yao Xue Xue Bao 1996;31(2):91-94.
23. Bhattacharya SK, Upadhyay SN, Jaiswal AK: Effect of piracetam on electroshock induced amnesia and decrease in acetyl choline in rats. Indian J Exp Biol 1993;31:822-824.
24. Canonico PL, Aronica E, Aleepo G, Casabona G, Copani A, Favit A, Nicoletti F, Scapagnini U: Repeated injections of piracetam improve spatial learning and increase the stimulation of inositol phospholipid hydrolysis by excitatory amino acids in aged rats. Funct Neurol 1991;6:107-111.
25. Houghton PJ: The scientific basis for the reputed activity of valerian. J Clin Pharmacol 1999;51:505-512.